BATTLE-2 program: A biomarker-integrated targeted therapy study in previously treated patients with advanced non-small cell lung cancer (NSCLC).

Authors

null

Vassiliki Papadimitrakopoulou

Department of Thoracic Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX

Vassiliki Papadimitrakopoulou , Ignacio Ivan Wistuba , J. Jack Lee , Anne S. Tsao , Neda Kalhor , Frank V. Fossella , John Heymach , Christine M Alden , Scott N. Gettinger , Kevin R. Coombes , Pierre Saintigny , Ximing Tang , Emily Duffield , Julie Boyer , Suzanne E Davis , Garth Powis , David J. Mauro , Eric H. Rubin , Waun Ki Hong , Roy S. Herbst

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2013 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Lung Cancer - Non-small Cell Metastatic

Track

Lung Cancer

Sub Track

Metastatic Non–Small Cell Lung Cancer

Clinical Trial Registration Number

NCT01248247

Citation

J Clin Oncol 31, 2013 (suppl; abstr TPS8118)

DOI

10.1200/jco.2013.31.15_suppl.tps8118

Abstract #

TPS8118

Poster Bd #

42B

Abstract Disclosures

Similar Posters

First Author: Vassiliki Papadimitrakopoulou

Poster

2015 ASCO Annual Meeting

Targeting c-Met overexpression for overcoming acquired resistance to EGFR TKIs in NSCLC.

Targeting c-Met overexpression for overcoming acquired resistance to EGFR TKIs in NSCLC.

First Author: Lanying Gou Jr.

First Author: Giuseppe Giaccone